Key Facts Surrounding This News Item
- ADXS had returned +6.69% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.
More Info About Advaxis, Inc. (ADXS)
Advaxis Inc. is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary Lm Technology. The company was founded in 2002 and is based in Princeton, New Jersey. View our full ADXS ticker page with ratings, news, and more.